https://scholars.lib.ntu.edu.tw/handle/123456789/592776
標題: | Comparison of guidelines for the management of hypertension: Similarities and differences between international and Asian countries; perspectives from HOPE-Asia Network | 作者: | Chia, Yook-Chin Turana, Yuda Sukonthasarn, Apichard Zhang, Yuqing Shin, Jinho Cheng, Hao-Min Tay, Jam Chin Tsoi, Kelvin Siddique, Saulat Verma, Narsingh Buranakitjaroen, Peera Sogunuru, Guru P Nailes, Jennifer Van Minh, Huynh Park, Sungha Teo, Boon W Chen, Chen-Huan TZUNG-DAU WANG Soenarta, Arieska A Hoshide, Satoshi Wang, Ji-Guang Kario, Kazoumi |
關鍵字: | Asian countries; HOPE-Asia Network; diagnosis; guidelines; hypertension; target blood pressure | 公開日期: | 三月-2021 | 出版社: | WILEY | 卷: | 23 | 期: | 3 | 起(迄)頁: | 422 | 來源出版物: | Journal of clinical hypertension (Greenwich, Conn.) | 摘要: | Guidelines on the management of hypertension have been developed by various professional bodies and institutions to primarily address the issues of diagnosis, treatment, and control in order to rationalize and improve the management of hypertension. Hypertension guidelines across the world have recently been updated following the new and controversial lower blood pressure threshold of ≥130/80 mmHg for the diagnosis of hypertension adopted by the Americans. While there are differences between the major as well as between the Asian national guidelines, there were also many similarities. This paper discusses and highlights the differences and similarities between the major international guidelines of the American College of Cardiology/American Heart Association, of the European Society of Cardiology/European Society of Hypertension, and of the International Society of Hypertension and also compares them with the Asian guidelines. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/592776 | ISSN: | 1524-6175 | DOI: | 10.1111/jch.14226 | SDG/關鍵字: | angiotensin receptor antagonist; beta adrenergic receptor blocking agent; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; Asia; blood pressure measurement; blood pressure monitoring; cardiovascular risk; cerebrovascular accident; chronic kidney failure; chronology; coronary artery disease; decision making; diabetes mellitus; Europe; geographic distribution; geriatrics; heart failure; Hong Kong; human; hypertension; India; Indonesia; Malaysia; medical society; multiple sclerosis; Pakistan; Philippines; practice guideline; Review; risk assessment; Singapore; Taiwan; Thailand; United States; Viet Nam; blood pressure; cardiology; hypertension; hypotension; American Heart Association; Asia; Blood Pressure; Cardiology; Humans; Hypertension; Hypotension; United States |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。